# Perioperative Intensive Statin Therapy for Neuroprotection in TAVR（PISTNT）

Study · id `cardio:ct-nct07087379` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07087379](<https://clinicaltrials.gov/study/NCT07087379>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07087379

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT07087379. Randomized; triple masking; primary purpose prevention. Start 2025-10-01 (anticipated); primary completion 2027-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT07087379, source copy `cardio:ctgov-nct07087379-2025-07-28`, retrieved 2026-10-26)
- Planned start: 2025-10-01 (anticipated) (ClinicalTrials.gov record NCT07087379, source copy `cardio:ctgov-nct07087379-2025-07-28`, retrieved 2026-10-26)
- Primary completion: 2027-10-01 (anticipated) (ClinicalTrials.gov record NCT07087379, source copy `cardio:ctgov-nct07087379-2025-07-28`, retrieved 2026-10-26)
- Completion: 2028-01-01 (anticipated) (ClinicalTrials.gov record NCT07087379, source copy `cardio:ctgov-nct07087379-2025-07-28`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07087379-2025-07-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Perioperative Intensive Statin Therapy for Neuroprotection in TAVR（PISTNT）
- Acronym: PISTNT
- Condition: Aortic Stenosis
- Condition: Cerebral Ischaemic Injury
- Intervention (Drug): Intensive statin treatment
- Intervention (Drug): Placebo Control
- Lead sponsor: Pan Xiangbin
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 5cd61ad14b5ba05df0cae076ba7794daf31a89e857d82f1b52bf7b8f050656a7
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
